ReviewFrontiers in immunology2025

Exosomal PD-L1 detection in cancer predictive biomarker for response to immune checkpoint blockade therapy.

Tetsuichi Kansha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.